Options for screening for gestational diabetes mellitus during the SARS-CoV-2 pandemic

David Simmons; Victoria L. Rudland; Vincent Wong; Jeff Flack; Adam Mackie; Glynis P. Ross; Suzette Coat; Raiyomand Dalal; Bill M. Hague; Ngai Wah Cheung

doi:10.1111/ajo.13224

Options for screening for gestational diabetes mellitus during the SARS-CoV-2 pandemic

David Simmons, Victoria L. Rudland, Vincent Wong, Jeff Flack, Adam Mackie, Glynis P. Ross, Suzette Coat, Raiyomand Dalal, Bill M. Hague, Ngai Wah Cheung

Western Sydney University

Research output: Contribution to journal › Article › peer-review

Abstract

The balance between avoiding severe acute respiratory syndrome coronavirus-2 contagion and reducing wider clinical risk is unclear for gestational diabetes mellitus (GDM) testing. Recent recommendations promote diagnostic approaches that limit collection but increase undiagnosed GDM, which potentially increases adverse pregnancy outcome risks. The most sensitive approach to detecting GDM at 24–28 weeks beyond the two-hour oral glucose tolerance test (OGTT) is a one- hour OGTT (88% sensitivity). Less sensitive approaches use fasting glucose alone (≥5.1 mmol/L: misses 44–54% GDM) or asking ~20% of women for a second visit (fasting glucose 4.7–5.0 mmol/L (62–72% sensitive)). Choices should emphasise local and patient decision-making.

Original language	English
Pages (from-to)	660-666
Number of pages	7
Journal	Australian and New Zealand Journal of Obstetrics and Gynaecology
Volume	60
Issue number	5
DOIs	https://doi.org/10.1111/ajo.13224
Publication status	Published - 2020

Keywords

COVID-19 (disease)
diabetes in pregnancy
diagnosis
stillbirth

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/ajo.13224

Cite this

@article{67df73c55c984643a9cf4fca82cef127,

title = "Options for screening for gestational diabetes mellitus during the SARS-CoV-2 pandemic",

abstract = "The balance between avoiding severe acute respiratory syndrome coronavirus-2 contagion and reducing wider clinical risk is unclear for gestational diabetes mellitus (GDM) testing. Recent recommendations promote diagnostic approaches that limit collection but increase undiagnosed GDM, which potentially increases adverse pregnancy outcome risks. The most sensitive approach to detecting GDM at 24–28 weeks beyond the two-hour oral glucose tolerance test (OGTT) is a one- hour OGTT (88% sensitivity). Less sensitive approaches use fasting glucose alone (≥5.1 mmol/L: misses 44–54% GDM) or asking ~20% of women for a second visit (fasting glucose 4.7–5.0 mmol/L (62–72% sensitive)). Choices should emphasise local and patient decision-making.",

keywords = "COVID-19 (disease), diabetes in pregnancy, diagnosis, stillbirth",

author = "David Simmons and Rudland, {Victoria L.} and Vincent Wong and Jeff Flack and Adam Mackie and Ross, {Glynis P.} and Suzette Coat and Raiyomand Dalal and Hague, {Bill M.} and Cheung, {Ngai Wah}",

year = "2020",

doi = "10.1111/ajo.13224",

language = "English",

volume = "60",

pages = "660--666",

journal = "Australian and New Zealand Journal of Obstetrics and Gynaecology",

issn = "1479-828X",

publisher = "Wiley-Blackwell Publishing Asia",

number = "5",

}

TY - JOUR

T1 - Options for screening for gestational diabetes mellitus during the SARS-CoV-2 pandemic

AU - Simmons, David

AU - Rudland, Victoria L.

AU - Wong, Vincent

AU - Flack, Jeff

AU - Mackie, Adam

AU - Ross, Glynis P.

AU - Coat, Suzette

AU - Dalal, Raiyomand

AU - Hague, Bill M.

AU - Cheung, Ngai Wah

PY - 2020

Y1 - 2020

N2 - The balance between avoiding severe acute respiratory syndrome coronavirus-2 contagion and reducing wider clinical risk is unclear for gestational diabetes mellitus (GDM) testing. Recent recommendations promote diagnostic approaches that limit collection but increase undiagnosed GDM, which potentially increases adverse pregnancy outcome risks. The most sensitive approach to detecting GDM at 24–28 weeks beyond the two-hour oral glucose tolerance test (OGTT) is a one- hour OGTT (88% sensitivity). Less sensitive approaches use fasting glucose alone (≥5.1 mmol/L: misses 44–54% GDM) or asking ~20% of women for a second visit (fasting glucose 4.7–5.0 mmol/L (62–72% sensitive)). Choices should emphasise local and patient decision-making.

AB - The balance between avoiding severe acute respiratory syndrome coronavirus-2 contagion and reducing wider clinical risk is unclear for gestational diabetes mellitus (GDM) testing. Recent recommendations promote diagnostic approaches that limit collection but increase undiagnosed GDM, which potentially increases adverse pregnancy outcome risks. The most sensitive approach to detecting GDM at 24–28 weeks beyond the two-hour oral glucose tolerance test (OGTT) is a one- hour OGTT (88% sensitivity). Less sensitive approaches use fasting glucose alone (≥5.1 mmol/L: misses 44–54% GDM) or asking ~20% of women for a second visit (fasting glucose 4.7–5.0 mmol/L (62–72% sensitive)). Choices should emphasise local and patient decision-making.

KW - COVID-19 (disease)

KW - diabetes in pregnancy

KW - diagnosis

KW - stillbirth

UR - http://hdl.handle.net/1959.7/uws:57059

U2 - 10.1111/ajo.13224

DO - 10.1111/ajo.13224

M3 - Article

SN - 1479-828X

SN - 0004-8666

VL - 60

SP - 660

EP - 666

JO - Australian and New Zealand Journal of Obstetrics and Gynaecology

JF - Australian and New Zealand Journal of Obstetrics and Gynaecology

IS - 5

ER -

Options for screening for gestational diabetes mellitus during the SARS-CoV-2 pandemic

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this